GSK Long Term Deferred Assets (Quarterly) Insights

GSK Plc (GSK)

59.52 -1.33 (-2.19%) USD | NYSE | Feb 20, 16:00

59.53 +0.01 (+0.02%) Pre-Market: 20:00

View Long Term Deferred Assets (Quarterly) for GSK.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Long Term Deferred Assets (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Long Term Deferred Assets (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Long Term Deferred Assets (Quarterly) Benchmarks

Start Trial

AstraZeneca PLC	Upgrade
Mereo BioPharma Group Plc	--
Novavax, Inc.	--
Biodexa Pharmaceuticals Plc	--
AnaptysBio, Inc.	--